PIGV anticorps (N-Term)
Aperçu rapide pour PIGV anticorps (N-Term) (ABIN630452)
Antigène
Voir toutes PIGV AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- PIGV antibody was raised against the N terminal of PIGV
-
Purification
- Purified
-
Immunogène
- PIGV antibody was raised using the N terminal of PIGV corresponding to a region with amino acids FVDQLVEGLLGGLSHWDAEHFLFIAEHGYLYEHNFAFFPGFPLALLVGTE
-
-
-
-
Indications d'application
-
WB: 1 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PIGV Blocking Peptide, (ABIN938497), is also available for use as a blocking control in assays to test for specificity of this PIGV antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PIGV antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PIGV (Phosphatidylinositol Glycan Anchor Biosynthesis, Class V (PIGV))
-
Autre désignation
- PIGV
-
Sujet
- Glycosylphosphatidylinositol (GPI) is a complex glycolipid that anchors many proteins to the cell surface. The biosynthetic pathway of GPI is mediated by sequential addition of sugars and other components to phosphatidylinositol. PIGV adds the second mannose to the GPI core.
-
Poids moléculaire
- 56 kDa (MW of target protein)
-
Pathways
- Inositol Metabolic Process
Antigène
-